Agon Hyseni

Agon Hyseni

Genmab - Copenhagen / Denmark
Others
AD Scientific Index ID: 4971005
person_outline Agon Hyseni's MOST POPULAR ARTICLES
1-) A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes … DC Klonoff, ML Evans, W Lane, HP Kempe, E Renard, JH DeVries, ... Diabetes, Obesity and Metabolism 21 (4), 961-967, 2019 772019
2-) A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A H Eichler, P Angchaisuksiri, K Kavakli, P Knoebl, J Windyga, ... Journal of Thrombosis and Haemostasis 16 (11), 2184-2195, 2018 552018
3-) Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome A Hyseni, H Kemperman, DW de Lange, J Kesecioglu, PG de Groot, ... Blood, The Journal of the American Society of Hematology 123 (14), 2153-2156, 2014 522014
4-) Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patientsA Hyseni, M Roest, SL Braun, AD Barendrecht, PG de Groot, G Ndrepepa, ...Thrombosis Research 131 (3), 198-203, 2013352013
5-) Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expressionA Hyseni, P Van Der Groep, E Van Der Wall, PJ Van DiestCellular oncology 34, 565-570, 2011292011